Repurposing of the Fasciolicide Triclabendazole to Treat Infections Caused by Staphylococcus spp. and Vancomycin-Resistant Enterococci

One approach to combat the increasing incidence of multidrug-resistant (MDR) bacterial pathogens involves repurposing existing compounds with known safety and development pathways as new antibacterial classes with potentially novel mechanisms of action. Here, triclabendazole (TCBZ), a drug originall...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Hongfei, Ogunniyi, Abiodun D., Savaliya, Bhumi, Nguyen, Hang Thi, Page, Stephen W., Lacey, Ernest, Venter, Henrietta, Trott, Darren J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398527/
https://www.ncbi.nlm.nih.gov/pubmed/34442776
http://dx.doi.org/10.3390/microorganisms9081697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398527/
https://www.ncbi.nlm.nih.gov/pubmed/34442776
http://dx.doi.org/10.3390/microorganisms9081697

Ejemplares similares